Analysts think LNSR stock price could increase by 102%
Aug 10, 2024, 6:25 AM
12.28%
What does LNSR do
LENSAR, Inc., headquartered in Orlando, Florida with 110 employees, specializes in femtosecond laser technology for refractive cataract surgery, launching its IPO in 2020. The company offers the LENSAR Laser System and the ALLY Adaptive Cataract Treatment System, enhancing surgical outcomes with proprietary technologies.
3 analysts think LNSR stock price will increase by 102.48%. The current median analyst target is $8.16 compared to a current stock price of $4.03. The lowest analysts target is $8.08 and the highest analyst target is $8.40.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.